Download Files:
Tavilermide
$180 – $3,960
Products Details
Product Description
– Tavilermide is a selective, partial agonist of TrkA, or a nerve growth factor (NGF) mimetic.
Web ID
– HY-17622
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C24H32N6O11
References
– [1]Meerovitch K, et al. Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye. Clin Ophthalmol. 2013;7:1275-85.
CAS Number
– 263251-78-1
Molecular Weight
– 580.54
Compound Purity
– 98.98
SMILES
– O=C(O)CC[C@H](N1)C(N[C@@H](CCCCN)C(N[C@H](C(NCC(O)=O)=O)CCOC2=CC=C([N+]([O-])=O)C=C2C1=O)=O)=O
Clinical Information
– Phase 3
Research Area
– Inflammation/Immunology
Solubility
– H2O : 2 mg/mL (ultrasonic)|NH4OH : 50 mg/mL (ultrasonic;adjust pH to 10 with NH4OH)
Target
– Trk Receptor
Isoform
– TrkA
Pathway
– Neuronal Signaling;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
